High-dose pilot study with the novel progestogen dienogestin patients with endometriosis

References

• Schindler A E. Pathophysiology, diagnosis and treatment of endometriosis. Minerva Ginecol 2004; 56: 419–435
   PubMedGoogle Scholar
• American Society of Reproductive Medicine. Revised American Society of Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817–821
   PubMed Web of Science ®Google Scholar
• Shaw R. An open randomized comparative study of the effect of goserelin depot and danzol in the treatment of endometriosis. Fertil Steril 1992; 58: 265–272
   PubMed Web of Science ®Google Scholar
• Regidor P A, Schindler A E, Buhler K, Gerhard I, Kimmig R, Meinen K, Hoffmann G, Lubben G, Kienle E. Ergebnisse eines Langzeit-Follow-up bei der Behandlung der Endometriose mit dem GnRH-Agonisten Leuprorelinazetat-Depot (Enantone-Gyn®, Monatsdepot). Zentralbl Gynakol 1996; 118: 283–290
   PubMedGoogle Scholar
• Regidor P A, Regidor M, Kato K, Bier U W, Bühler K, Schindler A E. Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelin acetate (Suprecur®) were evaluated in respect of recurrence of pain symptoms and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 1997; 573: 153–160
   Google Scholar
• Vercellini P, Cortesi I, Crosignani P G. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 1997; 68: 393–401
   PubMed Web of Science ®Google Scholar
• Oettel M, Carol W, Elger W, Kaufmann G, Moore C, Römer W, Klinger G, Schneider B, Schröder J, Sobek L, et al. A 19-norprogestogen without 17α-ethinyl group. II. Dienogest from a pharmacodynamic point of view. Drugs Today 1995; 31: 517–536
   Google Scholar
• Moore C, Carol W, Gräser T, Mellinger U, Walter F. Influence of dienogest on ovulation in young fertile women. Clin Drug Invest 1999; 18: 271–278
   Web of Science ®Google Scholar
• Cosson M, Querleu D, Donnez J, Madelenat P, Konincks P, Audebert A, Manhes H. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertil Steril 2002; 77: 684–692
   PubMed Web of Science ®Google Scholar
• Taubert H D, Kuhl H. Kontrazeption mit Hormonen2nd ed. Georg Thieme Verlag, Stuttgart 1995
   Google Scholar
• Telimaa S, Rönnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987; 1: 13–23
   PubMedGoogle Scholar
• Fedele L, Bianchi S, Bocciolone L, Di Nola G, Parazzini F. Pain symptoms associated with endometriosis. Obstet Gynecol 1992; 79: 767–769
   PubMed Web of Science ®Google Scholar
• American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985; 43: 351–352
   PubMed Web of Science ®Google Scholar
• Henkel A, Christensen B, Schindler A E. Endometriosis a clinically malignant disease. Eur J Obstet Gynecol 1999; 82: 209–211
   Google Scholar
• Moore C, Köhler G, Müller A. The treatment of endometriosis with dienogest. Drugs Today 1999; 35: 41–53
   Web of Science ®Google Scholar
• Barbieri R L. Gonadotropin-releasing hormone agonists: treatment of endometriosis. Clin Obstet Gynecol 1993; 36: 636–641
   PubMed Web of Science ®Google Scholar
• Shaw R W. Treatment of endometriosis. Lancet 1992; 340: 1267–1271
   PubMed Web of Science ®Google Scholar
• Dmowski W P. The role of medical management in the treatment of endometriosis. Endometriosis – Advanced management and surgical techniques, C R Nezhat, G S Berger, F R Nezhat, V C Buttram, C H Nezhat. Springer, New York 1995; 229–240
   Google Scholar
• Moghissi K S. Treatment of endometriosis with estrogen–progestin combination and progestogens alone. Clin Obstet Gynecol 1988; 31: 823–828
   PubMed Web of Science ®Google Scholar
• Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani P G. Gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993; 60: 75–79
   PubMed Web of Science ®Google Scholar
• Lemay A, Maheux R. GnRH agonists treatment of endometriosis: the addition of steroidal and non-steroidal regimes. Progress in the management of endometriosis, M Coutinho. Parthenon Publishing, London 1995; 265–273
   Google Scholar
• Moghissi K S, Boyce F, Boyce C R. Management of endometriosis with oral medroxyprogesterone acetate. Obstet Gynecol 1976; 47: 265–267
   PubMed Web of Science ®Google Scholar